lobbying_activities: 2635678

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2635678 f61f83b1-c75c-4b20-8cec-bbd2d921a798 Q2 RIVENDELL GROUP LLP 401103952 GENENTECH 2021 second_quarter MMM Issues related to Medicare and Medicaid coverage and reimbursement, drug pricing, the 340B Drug Discount Program, and issues related to the International Pricing Index for Medicare Part B and general reference pricing. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-07-12T22:56:23.767000-04:00